Andere Sprachen GeneOne Life Science, Inc.

Aktien

A011000

KR7011000007

A011000

Schlusskurs Korea S.E. Andere Börsenplätze 00:00:00 14.05.2024			% 5 Tage	% 1. Jan.
2 410 ^KRW	0,00 %		0,00 %	-15,14 %

27.03.	GeneOne Life Science, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
2023	GeneOne Life Science, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

GeneOne Life Science, Inc. announced that it has received KRW 3.6000014 billion in funding	28.03.
GeneOne Life Science, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27.03.
GeneOne Life Science, Inc. announced that it expects to receive KRW 3.6000014 billion in funding	21.03.
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14.11.
GeneOne Life Science, Inc. announced that it has received KRW 2.46998556 billion in funding	15.09.23
Gene One Life Science to Raise 2.5 Billion Won via Stock Sale	07.09.23
GeneOne Life Science, Inc. announced that it expects to receive KRW 2.46998556 billion in funding	06.09.23
GeneOne Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14.08.23
Gene One Life Science to Raise 80 Billion Won via Share Sale	17.05.23
GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15.05.23
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14.11.22
Varicella Zoster Infections Pipeline Landscape Analysis of 03+ Companies by DelveInsight \| Leading Companies - Curevo Vaccine, GeneOne Life Science, SK Bioscience, and Others	04.10.22
GeneOne Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16.08.22
GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16.05.22
GeneOne Life Science, Inc. announced that it has received KRW 11.7 billion in funding	15.04.22
GeneOne Life Science, Inc. announced that it expects to receive KRW 11.7 billion in funding	13.04.22
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	08.11.21
SK bioscience : S.Korea to begin producing Novavax COVID-19 vaccine as early as June	12.04.21
GeneOne Life Science : VGXI and Geneos Therapeutics Expand Partnership for Personalized Cancer Immunotherapies	17.03.21
GeneOne Life Science, Inc. announced that it has received KRW 24 billion in funding from a group of investors	25.11.20

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen GeneOne Life Science, Inc.

Aktien

A011000

KR7011000007

A011000

Andere Sprachen

Filter